Wordt geladen...

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial

Objective: Because cholinergic deficits are prominent in dementia with Lewy bodies (DLB), we investigated the effects of a cholinesterase inhibitor, donepezil, in such patients in a randomized, double-bilnd- placebo-controlled exploratory phase 2 trial. Methods: One-hundred forty patients with DLB,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mori, Etsuro, Ikeda, Manabu, Kosaka, Kenji
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley Subscription Services, Inc., A Wiley Company 2012
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3504981/
https://ncbi.nlm.nih.gov/pubmed/22829268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23557
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!